November 13

Review spotlights key plant compounds with anti-viral potential

0  comments

[ad_1]

The bioactive plant-derived epi-nutraceuticals reported in the review include apigenin, curcumin, quercetin, berberine,โ€‹ resveratrol, genistein and sulforaphane.

Some compounds are observed to have a broad-spectrum anti-viral activity, inhibiting both RNA and DNA viruses, with curcumin and glycyrrhizin acid are observed to be the most effective.

The โ€˜Nutrientsโ€™ published report emphasises: โ€œEpigenetic therapies might be used in the future in conjunction with standard antiviral drugs or vaccines to increase their efficacy.

โ€œBy altering host factors, epigenetic therapies can create a hostile environment for viral replication and make viruses more susceptible to the direct antiviral effects of conventional drugs,โ€ the report concluded.

Anti-viral plantsโ€‹

Following the continued emergence of SARS-CoV-2 variants, there has been a renewed awareness of the threat of viral infections to humans, the authors note.

They point out that whilst vaccinations are essential for such wide-spread infections, drugs and natural alternatives are critical for those with compromised immune systems or those with restricted access. They add that plant-derived products with anti-viral activities present strong potential as novel therapeutics, whilst overcoming sustainability and cost challenges.

Epigenetic modification to affect gene expression within the genome presents a mechanism to silence incoming viral molecules. Thus, the researchers sought to investigate the potentials of plant-derived substances as epigenetic modifiers for anti-viral activity.

[ad_2]

Source link


Tags

bioactives, Botanicals, Immune support, Immune system, Inflammation, Nutraceutical, Research, Supplements, Virus


You may also like

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350